We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Aortech International Plc | LSE:AOR | London | Ordinary Share | GB0033360586 | ORD 5P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 126.50 | 123.00 | 130.00 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
09/5/2013 16:35 | Great News for us!!!! By Michelle Fay Cortez - May 9, 2013 4:16 PM GMT+0100 St. Jude Medical Inc. (STJ)'s Durata lead, the wire used to connect life-saving defibrillators to the heart, proved safe and reliable in an independent review that should ease concerns about its use, researchers said. Questions lingered about the Durata leads since an older version known as Riata was pulled off the market in 2010 because the internal wires could break through the protective coating. While no evidence showed a similar problem with Durata, which has stronger insulation, some doctors have shied away from using it. Medtronic Inc. (MDT) and Boston Scientific Corp. (BSX) have increased their share of the $6 billion market, according to data compiled by Bloomberg. The review of more than 11,000 Durata wires presented at the Heart Rhythm Society meeting in Denver today found mechanical failures in just 38 cases. There were no problems seen with wires coming out of their casing, said John Cairns, a cardiologist at the University of British Columbia. The results bolster two smaller studies presented yesterday that found the leads performed as well as the current market leaders. "It looks very reassuring for someone who has one of these leads," Cairns said in a telephone interview. "Their chance of having a mechanical failure by five years is about six in 1,000, and most are picked up by routine monitoring," he said. It's too soon to know whether the risks will increase after six or seven years, Cairns said. At the five-year mark, however, the risk with Durata is significantly lower than what was seen with the older Riata devices, he said. St. Jude, based in St. Paul, Minnesota, asked the Population Health Research Institute at Hamilton Health Sciences and McMaster University in Ontario to conduct an independent review of three databases enrolling patients with Durata or newer Riata ST devices coated with the new Optim insulation. The researchers examined every reported failure with the devices for patients in the registries through February 2013. To contact the reporter on this story: Michelle Fay Cortez in Minneapolis at mcortez@bloomberg.ne | gac141 | |
12/4/2013 18:35 | Footnote - Directors cannot buy if there is stuff happening that they know about. The Fact that they are not buying (though they may want to), could be indicative. | piccolino3 | |
12/4/2013 14:20 | I think anyone with an iota of sense will see the message in Roy's comment... | gac141 | |
12/4/2013 10:00 | October, If the Directors of the company are working flat out in the interest of shareholders: 1) There would be an update on progress since STJ resolution 2) There would be an RNS stating "we know of no reason for the share price fall" (from 100p to current level) 3) There would be director purchases 4) The tireless work that they are doing would be recognised by the company broker and they would be advising clients to buy shares | papillon88 | |
12/4/2013 07:26 | Given the holdings the guys have I am sure Roy is right that they are working flat out for shareholders. I think they have done really well since mid 2012 to sort out the issues ..we all hope that the work they are putting in gets us all out at a sensible price. | harrogate | |
12/4/2013 06:43 | David I think you should listen to Roy. He rarely posts and what he says is the truth. | gac141 | |
11/4/2013 21:08 | I met with them last week and I can assure they that they are working flat out in the interests of shareholders | 25october1969 | |
11/4/2013 20:57 | Not alot on offer from the Bill & eddie roadshow these days. Perhaps they have been to busy spending their ill gotten loan note gains whilst still drawing down their nice monthly salaries. | cocker | |
28/3/2013 16:15 | Lower and lower the share price goes the Only winners here are the directors they made a 100% return on the loan notes and are still drawing salaries while watching share holder value being destroyed. Like I said before a lot of confidence would be generated by a small purchase by directors.We all know that's not going to happen though. A 30% fall in price since STJ resolution but the only announcement weve had is another court case. Ive had shares fall 10% and had companies issue an rns "knowing of no reason for the fall."Is this the so called strategy trying to take people to court rather than focussing on the business.seems very desperate. I really hope I'm proved wrong but up to now Ive been spot on predicting the share price demise and can only see this continuing | papillon88 | |
25/3/2013 16:00 | Says a lot when the directors made a 100% return on the loan note yet they haven't bought any shares. why is there still this optimism from shareholders when it's clear that directors don't feel the same. | papillon88 | |
22/3/2013 10:54 | I take the point but in a way I would be disappointed if they were in a position to buy since I hope they are in discussions with parties of such a nature that would make that against the rules!! | harrogate | |
22/3/2013 10:41 | It is perhaps significant Aor announced legal proceedings via arbritation rather than going straight for the jugular.This reinforces the confidence expressed in the validity and strength of the claim and imo suggests an expectation of an early settlement rather than a long drawn out court battle which suits neither party. Landy90 has raised an interesting scenario and it would be surprising if the two parties hadnt already had informal discussions. All guesswork but imo very positive for Aor. Final point I think all long term holders would acknowledge the outstanding recent job Bill and Eddie have done and I feel were the Board to show their faith by buying some additional shares it would send a powerful message to the doom and gloomers and work wonders for the share price regards SP | spurious | |
22/3/2013 07:35 | Fair point landy90 maybe we might get a chunk of that eh? | gac141 | |
21/3/2013 20:14 | indeed, what an amazing (and hugely positive!) coincidence! ;-) | bearfoot | |
21/3/2013 19:52 | Syncardia announces a $19m fund raise on the same day Aortech starts legal proceedings .. What a coincidence, wonder if the legal filing was before or after completion? | landy90 | |
21/3/2013 14:25 | According to what I found on the 'net today, Syncardia have just received a cash infusion of $19 million. They have the money! | 1400 | |
21/3/2013 13:17 | David the only fiasco is the fact that Frank and Pither didn't do something about this many months ago. Pither has gone and Frank is on his best behaviour... Bill is grasping the nettle and doing things- He should be thanked for that! | gac141 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions